Global public perceptions of participation in pandemic and non-pandemic trials in the intensive care unit: a cross-sectional survey across 13 countries

Public views of clinical trial participation are not frequently sought. As potential patients and study participants, their views are profoundly important, particularly in the intensive care unit (ICU) where alternative consent models are required and for multi-centre trials enrolling diverse populations. To understand public opinions on pandemic and non-pandemic ICU trials, consent and emerging trial designs, following the COVID-19 pandemic. To identify factors associated with acceptability of clinical trials including in countries where public opinions have not been previously assessed. An international cross-sectional scenario-based online survey with responses collected from March 17 to April 10, 2023. The views of nationally representative quota samples of people in 13 countries; Australia, Canada, France, Germany, Ghana, India, Ireland, Italy, Japan, New Zealand, Pakistan, the United Kingdom and the United States of America were analysed using descriptive and regression analyses. Of 9726 survey respondents, 7382 (75.9%) felt pandemic research is important and should be established before a pandemic so it is ready to respond (76.1%). Respondents indicated that special rules should apply to make it quicker and easier to do pandemic research (72.8%) and that patients and public should be involved (73%). Fewer respondents would not agree to participate in low-risk (1627, 16.7%) and higher-risk (1823, 18.7%) pandemic ICU trials, and non-pandemic ICU trials (17.3%, asked in 9 countries). Respondents preferred alternative consent models (79.8%), including deferred and substitute decision maker consent, and were supportive of biological sample collection (71.4%), adaptive trials (79.6%) and precision medicine (80.8%). Prior experience of an ICU or pandemic illness, higher pandemic knowledge, trust in healthcare professionals and greater or uncertain therapeutic misconception were predictive of willingness to participate. Age and country-level differences in willingness were observed. Respondents had overall lower trust in their government to manage a pandemic outbreak (45.3%), also a predictive factor for agreement to participate. There is public support for pandemic and non-pandemic ICU trials with acceptance of alternative consent, biological sample collection and trial designs, but there is a need for researchers to further build trust and engage with the public to increase understanding and inform trials.

Authors

Institutions

Publication Details

Journal
Trials
Published
2026-10-13
DOI
https://doi.org/10.1186/s13063-026-10048-3
Primary Topic
Ethics in Clinical Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Global public perceptions of participation in pandemic and non-pandemic trials in the intensive care unit: a cross-sectional survey across 13 countries

Niamh Mahon, Ian Seppelt, Ewan C. Goligher, Alistair Nichol et al.
Trials
Ethics in Clinical Research
article

Global public perceptions of participation in pandemic and non-pandemic trials in the intensive care unit: a cross-sectional survey across 13 countries

Niamh Mahon, Ian Seppelt, Ewan C. Goligher, Alistair Nichol, Lieuwe D. J. Bos, Timo Tolppa, Anthony C. Gordon, Sabin Koirala, Radhika Maharjan, Colin J. McArthur, Rachael L. Parke, Heather K. O’Grady, Paul R. Mouncey, Kazuaki Jindai, Djillali Annane, Madiha Hashmi, Leanne M. C. Hays, Fiona Toal, Lewis T. Campbell, Emma Jean Ridley, Kathy Brickell, Arishay Hussaini, Lennie P. G. Derde, Daniel Francis McAuley, Jane C. Parker, Peter Doran, Marie Galligan, Anne McKenzie, Kathryn M. Rowan, Andrew J. Boyle, Steve A. Webb, Hiroki Saito, Aidan Burrell, Monika Kerckhoffs, Nao Ichihara, Cameron Green, Srinivas Murthy, Rashan Haniffa, Attia Fatima, Alex C. Sherry, Kate Ainscough, Frank M. Brunkhorst, John C. Marshall, Nina Gobat, The ICC-PPI group
article en

Abstract

Public views of clinical trial participation are not frequently sought. As potential patients and study participants, their views are profoundly important, particularly in the intensive care unit (ICU) where alternative consent models are required and for multi-centre trials enrolling diverse populations. To understand public opinions on pandemic and non-pandemic ICU trials, consent and emerging trial designs, following the COVID-19 pandemic. To identify factors associated with acceptability of clinical trials including in countries where public opinions have not been previously assessed. An international cross-sectional scenario-based online survey with responses collected from March 17 to April 10, 2023. The views of nationally representative quota samples of people in 13 countries; Australia, Canada, France, Germany, Ghana, India, Ireland, Italy, Japan, New Zealand, Pakistan, the United Kingdom and the United States of America were analysed using descriptive and regression analyses. Of 9726 survey respondents, 7382 (75.9%) felt pandemic research is important and should be established before a pandemic so it is ready to respond (76.1%). Respondents indicated that special rules should apply to make it quicker and easier to do pandemic research (72.8%) and that patients and public should be involved (73%). Fewer respondents would not agree to participate in low-risk (1627, 16.7%) and higher-risk (1823, 18.7%) pandemic ICU trials, and non-pandemic ICU trials (17.3%, asked in 9 countries). Respondents preferred alternative consent models (79.8%), including deferred and substitute decision maker consent, and were supportive of biological sample collection (71.4%), adaptive trials (79.6%) and precision medicine (80.8%). Prior experience of an ICU or pandemic illness, higher pandemic knowledge, trust in healthcare professionals and greater or uncertain therapeutic misconception were predictive of willingness to participate. Age and country-level differences in willingness were observed. Respondents had overall lower trust in their government to manage a pandemic outbreak (45.3%), also a predictive factor for agreement to participate. There is public support for pandemic and non-pandemic ICU trials with acceptance of alternative consent, biological sample collection and trial designs, but there is a need for researchers to further build trust and engage with the public to increase understanding and inform trials.

Trials
University College Dublin (IE), Queen's University Belfast (GB), The University of Sydney (AU), University of British Columbia (CA), University of Auckland (NZ), St. Marianna University School of Medicine (JP), Flinders University (AU), The Kids Research Institute Australia (AU), University of Toronto (CA), Utrecht University (NL), Tohoku University (JP), Keio University (JP), Royal Perth Hospital (AU), Wellington Hospital (NZ), Auckland City Hospital (NZ), Nepean Hospital (AU), Beaumont Hospital (IE), The Alfred Hospital (AU), Niagara Health System (CA), University Medical Center Utrecht (NL), University of Oxford (GB), Assistance Publique – Hôpitaux de Paris (FR), Grande International Hospital (NP), Hôpital Raymond-Poincaré (FR), Jena University Hospital (DE), Medical Research Institute of New Zealand (NZ), Royal Darwin Hospital (AU), Centre for Inflammation Research (GB), Osaka University Hospital (JP), Intensive Care National Audit & Research Centre (GB), Unity Health Toronto, Imperial College London (GB), Monash University (AU), Ziauddin University (PK), The University of Osaka (JP), Macquarie University (AU)
Health Research Board, National Institute for Health and Care Research, Ministry of Health, Labour and Welfare, Canadian Institutes of Health Research
Openalex Percentile: Top 10%
Ethics in Clinical Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.